Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer.

1. Del Giglio A, Soares HP, Caparroz C et al. Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomit. Results of a meta-analysis of randomised controlled trials. Cancer 2000; 89: 2301–2308. 2. Grunberg SM. Phase I and other dose-ranging studies of granisetron. Semin Oncol 1992; 19 (Suppl 10): 16–22. 3. Perez EA, Hesketh P, Sandbach J et al. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicentric, double-blind, randomised parallel study. J Clin Oncol 1998; 16: 754–760. 4. Perez EA, Lembersky B, Kaywin P et al. Comparable safety and antiemetic efficacy of a brief (30-sec bolus) intravenous granisetron infusion and standard (15-min) intravenous ondansetron infusion in breast cancer patients receiving moderately chemotherapy. Cancer J Sci Am 1998; 4: 52–58. 5. Blower P. A pharmacological profile of oral granisetron (Kytril tablets). Semin Oncol 1995; 4 (Suppl 10): 3–5. 6. Tyers MB, Bunce KT, Humphrey PP. Pharmacological and anti-emetic properties of ondansetron. Eur J Cancer Clin Oncol 1989; 25 (Suppl 1): S15–S19.